Ireland
--:--IST
Recruiting Not applicable

QIPB in Inguinal Hernia

NCT06862609 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-03-23
Last updated
2026-03-11

Condition(s) studied

Postoperative Pain

Investigational drug(s) / intervention(s)

Quadro iliac plane blockControl group

Quadro iliac plane block: Patients in Group Q will be placed in the lateral position. A low-frequency convex transducer and a 100-mm block needle will be used. Following sterilization, the transducer will be placed parasagittally at the distal attachment of the quadratus lumborum muscle to the iliac crest. The iliac crest and quadratus lumborum muscle will be visualized, with the erector spinae muscle above and the psoas major muscle below. Using an in-plane technique, the needle will be directed toward the iliac crest. After confirmation with 5 mL of isotonic sodium chloride, 20 mL of 0.25% bupivacaine will be injected incrementally with intermittent aspiration. The same procedure will be applied to the other party. A total of 40 mL of 0.25% bupivacaine will be administered.

Control group: All patients will receive IV paracetamol (1 g, 3×1) and IV tenoxicam (20 mg, 2×1).

Study summary

Inguinal hernia repair is one of the most commonly performed surgical procedures. It is generally performed under regional anesthesia techniques, such as local anesthesia, peripheral nerve blocks, or neuraxial anesthesia (spinal or epidural anesthesia), or under general anesthesia. Despite various available analgesic regimens, numerous studies have demonstrated that postoperative pain control remains inadequate. Opioids, nonsteroidal anti-inflammatory drugs, and analgesics are frequently used for postoperative pain management. However, these medications are associated with uncertain efficacy and undesirable side effects. Pain is a critical factor in the postoperative period, contributing to delayed ambulation and paralytic ileus, ultimately hindering early discharge.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Patients aged 18-65 years * Undergoing elective, * unilateral laparoscopic inguinal hernia repair * Receiving general anesthesia Exclusion Criteria: * Patients who refuse to provide consent * Patients with contraindications to regional anesthesia * Patients with impaired consciousness * Patients with coagulopathy * Patients with infections at the block site * Emergency cases

Primary outcome measure(s)

  • The primary outcome is the QoR-15 score (0-150 point) at 24 hours postoperatively. — 24 hours
    The primary outcome is the QoR-15 score (0-150 point) at 24 hours postoperatively.

Trial sites (1)

FacilityCityRegionStatus
Konya City Hospital Konya Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06862609 on ClinicalTrials.gov ↗ ← All trials in Turkey